Levetiracetam Oral Solution Suppliers & Bulk Manufacturers
Available Forms: Oral solution
Available Strengths: 100 mg/mL
Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®
Category:
Antipsychotropic Drugs
Levetiracetam acts by binding to the SV2A protein in the brain, regulating neurotransmitter release and stabilizing neuronal activity. It is used to treat partial-onset, myoclonic, and generalized tonic-clonic seizures. The oral solution is ideal for pediatric and elderly patients or those with swallowing difficulties.
Levetiracetam Oral solution is available in Oral solution
and strengths such as 100 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levetiracetam Oral solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levetiracetam Oral solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levetiracetam Oral Solution is FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in adults and children aged 1 month and older. It complies with GMP standards, includes pediatric-specific dosing, and carries CNS adverse effect warnings. In the European Union, it is approved through national or mutual recognition procedures, requiring detailed Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). Formulations must meet bioavailability and stability criteria. The oral solution is valuable for patients with swallowing difficulties. Explore more formulations of Levetiracetam at Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing